1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Propensity score–matched cohort
Overall Cohort
0–6 Hours (n = 112)6–24 Hours (n = 112)P Value
Variable
 Age (median) (IQR) (yr)73 (62–81)75 (59–83).759
 Female61 (54.5%)59 (52.7%).773
 Baseline NIHSS (median) (IQR)17 (12–22)17 (12–22).985
Site of occlusion
 ICA25 (22.3%)26 (23.2%).991
 M167 (59.8%)67 (59.8%)
 M220 (17.9%)19 (17.0%)
CT-ASPECTS (median) (IQR)9 (8–10)9 (8–10).720
Time to intervention (median) (IQR) (hr)210 (157–266)691 (497–907)<.001
TICI 2b/3 revascularization106 (94.6%)104 (92.9%).593
sICH6 (5.4%)7 (6.2%).782
Functional outcome
 mRS 0–251 (45.5%)38 (33.9%).091
 mRS 629 (25.9%)19 (17.0%).096